- Advanced clinical states in prostate cancerHeather H Cheng
Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA 98109, USA
Urol Clin North Am 39:561-71. 2012..The authors define the current disease states and discuss implications for prognosis and treatment decisions, as well as the limitations of existing classifications and emerging discoveries...
- Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapyHeather H Cheng
University of Washington, Seattle, USA
J Hematol Oncol 8:51. 2015..This case report suggests that treatment with sipuleucel-T can rarely lead to PSA decline, may have dual activity against both prostate cancer and CLL, and that these findings warrant further investigation. ..
- Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxiaHeather H Cheng
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
PLoS ONE 8:e69239. 2013....